[{"id":"cdb52f9d-e84e-4a0b-b174-0ae6485a549d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05392699","created_at":"2022-05-26T17:55:55.253Z","updated_at":"2024-07-02T16:36:08.484Z","phase":"Phase 1","brief_title":"ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy","source_id_and_acronym":"NCT05392699","lead_sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","biomarkers":" IFNG","pipe":"","alterations":" ","tags":["IFNG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ABO2011"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 05/25/2022","start_date":" 05/25/2022","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 01/01/2027","study_completion_date":" 01/01/2027","last_update_posted":"2022-06-22"}]